Background: Regulating the use of genetic information in insurance is an issue of ongoing
international debate. In Australia, providers of life and other mutually rated insurance …

Considering the fluid nature of nano breakthroughs—and the delicate balance between
benefits and consequences as they apply to medicine—readers at all levels require a …

Clinical genome and exome sequencing is currently used in only a small fraction of patients,
yet large scale genomic initiatives are becoming more embedded in clinical services. This …

In an era of personalized medicine rife with population databases and international
consortia, genetic discrimination is once again moving to the forefront of the genetics policy …

The use of genetic testing has prompted the question of whether insurance companies
should be able to use predictive genetic test results (GTRs) in their risk classification of …

Introduction: Genetic discrimination (GD) in the context of life insurance is a perennial
concern in Australia and internationally. To address such concerns in Australia, an industry …

O CORPO DIGITALIZADO: Page 1 i ADRIANA ESPÍNDOLA CORRÊA O CORPO DIGITALIZADO:
BANCOS DE DADOS GENÉTICOS E SUA REGULAÇÃO JURÍDICA CURITIBA 2009 Page 2 ii …

Bioethicists often defend novel practices by drawing analogies with practices that we are
already familiar with and currently tolerate. If some novel practice is less bad than some …

Background Genetic renal diseases (GRD) are a heterogeneous and incompletely
understood group of disorders accounting for approximately 10% of those diagnosed with …

Loss coverage, defined as expected population losses compensated by insurance, is a
public policy criterion for comparing different risk-classification regimes. Using a model with …